140 related articles for article (PubMed ID: 10451877)
21. The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective.
Montebello JF; Hartson-Eaton M
Cancer Invest; 1989; 7(2):139-60. PubMed ID: 2477119
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of repeated sequential administrations of Re-186(Sn)HEDP as palliative therapy for painful skeletal metastases. Initial case reports of two patients.
Englaro EE; Schroder LE; Thomas SR; Williams CC; Maxon HR
Clin Nucl Med; 1992 Jan; 17(1):41-4. PubMed ID: 1371956
[TBL] [Abstract][Full Text] [Related]
23. Systemic radionuclide therapy in pain palliation.
Liepe K; Runge R; Kotzerke J
Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
[TBL] [Abstract][Full Text] [Related]
24. The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases.
Kasalický J; Krajská V
Eur J Nucl Med; 1998 Oct; 25(10):1362-7. PubMed ID: 9818274
[TBL] [Abstract][Full Text] [Related]
25. [32P] diphosphonate dose determination in patients with bone metastases from prostatic carcinoma.
Potsaid MS; Irwin RJ; Castronovo FP; Prout GR; Harvey WJ; Francis MD; Tofe AJ; Zamenhof RG
J Nucl Med; 1978 Jan; 19(1):98-104. PubMed ID: 413889
[TBL] [Abstract][Full Text] [Related]
26. The treatment of painful osseous metastases with phosphorus-32-labeled phosphates.
Silberstein EB
Semin Oncol; 1993 Jun; 20(3 Suppl 2):10-21. PubMed ID: 7684860
[TBL] [Abstract][Full Text] [Related]
27. Samarium-153 treatment of bone pain in patients with metastatic prostate cancer.
Petersen LJ; Lund L; Jønler M; Jakobsen M; Abrahamsen J
Dan Med Bull; 2010 Jun; 57(6):A4154. PubMed ID: 20515602
[TBL] [Abstract][Full Text] [Related]
28. 32P-sodium phosphate treatment of metastatic malignant disease.
Roberts DJ
Clin Nucl Med; 1979 Mar; 4(3):92-3. PubMed ID: 428168
[TBL] [Abstract][Full Text] [Related]
29. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
[TBL] [Abstract][Full Text] [Related]
30. The use of radioisotopes for palliation of metastatic bone pain.
Gkialas I; Iordanidou L; Galanakis I; Giannopoulos S
J BUON; 2008; 13(2):177-83. PubMed ID: 18555462
[TBL] [Abstract][Full Text] [Related]
31. Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP.
Storto G; Gallicchio R; Pellegrino T; Nardelli A; De Luca S; Capacchione D; Sirignano C; Pace L
Nucl Med Biol; 2013 May; 40(4):518-23. PubMed ID: 23522973
[TBL] [Abstract][Full Text] [Related]
32. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
Bayouth JE; Macey DJ; Kasi LP; Fossella FV
J Nucl Med; 1994 Jan; 35(1):63-9. PubMed ID: 7505819
[TBL] [Abstract][Full Text] [Related]
33. Rhenium-188-HEDP in the palliative treatment of bone metastases.
Liepe K; Hliscs R; Kropp J; Grüning T; Runge R; Koch R; Knapp FF; Franke WG
Cancer Biother Radiopharm; 2000 Jun; 15(3):261-5. PubMed ID: 10941533
[TBL] [Abstract][Full Text] [Related]
34. [Metabolic curietherapy with P-32 in bone metastases in breast cancer].
Navarro-Izquierdo AL; Baringo T; Domínguez J; Duque JJ; Martínez Comín L; Solsona F
Rev Esp Oncol; 1980; 27(1):101-6. PubMed ID: 6163183
[TBL] [Abstract][Full Text] [Related]
35. Phosphorus-32 for intractable bony pain from carcinoma of the prostate.
Burnet NG; Williams G; Howard N
Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):220-3. PubMed ID: 1702016
[TBL] [Abstract][Full Text] [Related]
36. A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer.
Nilsson S; Strang P; Aksnes AK; Franzèn L; Olivier P; Pecking A; Staffurth J; Vasanthan S; Andersson C; Bruland ØS
Eur J Cancer; 2012 Mar; 48(5):678-86. PubMed ID: 22341993
[TBL] [Abstract][Full Text] [Related]
37. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
Schoeneich G; Palmedo H; Dierke-Dzierzon C; Müller SC; Biersack HJ
Scand J Urol Nephrol; 1997 Oct; 31(5):445-8. PubMed ID: 9406304
[TBL] [Abstract][Full Text] [Related]
38. [Analgesic response and secondary effects in patients with osteoblastic metastasis, treated with Samarium 153 ethylenediaminotetramethylenephosphate].
Lovera C; Massardo T; Galleguillos MC; González P; Comparini B; Yáñez M; Fodor M; Gil MC; Araya G; Tomicic M
Rev Med Chil; 1998 Aug; 126(8):963-71. PubMed ID: 9830748
[TBL] [Abstract][Full Text] [Related]
39. Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
Franco P; Migliaccio F; Angelini V; Cante D; Sciacero P; Peruzzo Cornetto A; Casanova Borca V; Zeverino M; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
Cancer Invest; 2014 Nov; 32(9):458-63. PubMed ID: 25259607
[TBL] [Abstract][Full Text] [Related]
40. 186Re-HEDP for metastatic bone pain in breast cancer patients.
Lam MG; de Klerk JM; van Rijk PP
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S162-70. PubMed ID: 15118846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
